Toll-like receptor 9 antagonizes antibody affinity maturation

Area of Science:

• Immunology
• Vaccinology

Background:

• T cell-dependent antibody responses rely on B cell antigen presentation for affinity maturation.
• Germinal center formation in lymphoid organs is critical for robust antibody responses.

Purpose of the Study:

• To investigate the effect of Toll-like receptor 9 (TLR9) signaling on B cell antigen presentation and T cell-dependent antibody responses.
• To determine if TLR9 activation influences affinity maturation during antibody responses.

Main Methods:

• In vitro studies assessing B cell antigen capture, processing, and presentation.
• In vivo experiments using a mouse model with a TLR9 agonist (CpG).
• Analysis of antibody responses in a human clinical trial involving CpG administration.

Main Results:

• TLR9 signaling inhibited B cells' ability to capture, process, and present antigens to T cells in vitro.
• CpG administration in mice and humans increased antibody magnitude but did not enhance affinity maturation.
• TLR9 activation appears to decouple antibody magnitude from germinal center-dependent maturation processes.

Conclusions:

• TLR9 signaling can enhance antibody titers, potentially by increasing B cell activation.
• However, TLR9 activation may compromise the B cell functions essential for affinity maturation and high-quality antibody responses.
• Therapeutic strategies using TLR9 agonists should consider the trade-off between antibody magnitude and affinity maturation.